Song Hwa Choi, Young Mi Kim, Jung Min Lee, Sang Geon Kim
Index: Expert Opin. Drug Metab. Toxicol. 6(2) , 213-24, (2010)
Full Text: HTML
Comprehensive studies indicate that oltipraz exerts cancer chemopreventive effects. Oltipraz has other therapeutic potentials, which include anti-fibrotic effect, inhibition of insulin resistance, mitochondrial protection and cytoprotective effect against oxidative stress. Although antioxidant mechanisms may account for its cancer chemopreventive effect, details on the molecular mechanism still remain to be clarified.Two major metabolic pathways of oltipraz include oxidative desulfuration of the thione to yield 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiol-3-one and molecular rearrangement to 7-methyl-6,8-bis(methylthio)H-pyrrolo[1,2-a]pyrazine. In addition to the diverse pharmacological effects of oltipraz, the oxidized metabolites may have distinct biological effects on cell survival. The AMP-activated protein kinase pathway has been recognized as a key cascade for mitochondrial protection and cell survival events, which can be activated by the oxidized metabolites of oltipraz.In this review, the metabolic activation of oltipraz and the role of the cell signaling pathways in regulating the expression of Phase II genes and antioxidant activity are discussed with particular reference to their effects on mitochondrial protection and cell survival.In terms of therapeutic potential, the findings reviewed here demonstrate a therapeutic potential for oxidized metabolite of oltipraz and offer comparison of antioxidant capacity between metabolites and parent compound.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Oltipraz
CAS:64224-21-1 |
C8H6N2S3 |
Catalase overexpression prevents nuclear factor erythroid 2-...
2014-10-01 [Diabetes 63(10) , 3483-96, (2014)] |
Inhibition of colon carcinogenesis by post-initiation induct...
2009-06-01 [Oncol. Rep. 21(6) , 1559-65, (2009)] |
Oltipraz promotion of liver regeneration after partial hepat...
2009-04-01 [Arch. Pharm. Res. 32(4) , 625-35, (2009)] |
Pharmacokinetic interaction between oltipraz and silymarin i...
2009-01-01 [J. Pharm. Pharm. Sci. 12(1) , 1-16, (2009)] |
This month in APR.
2009-04-01 [Arch. Pharm. Res. 32(4) , 463-4, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved